CN104491795A - Traditional Chinese medicine composition for treating rheumatoid arthritis - Google Patents

Traditional Chinese medicine composition for treating rheumatoid arthritis Download PDF

Info

Publication number
CN104491795A
CN104491795A CN201410772037.6A CN201410772037A CN104491795A CN 104491795 A CN104491795 A CN 104491795A CN 201410772037 A CN201410772037 A CN 201410772037A CN 104491795 A CN104491795 A CN 104491795A
Authority
CN
China
Prior art keywords
radix
parts
chinese medicine
rheumatoid arthritis
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410772037.6A
Other languages
Chinese (zh)
Inventor
邓凤桂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUANGDONG JUZHICHENG TECHNOLOGY Co Ltd
Original Assignee
GUANGDONG JUZHICHENG TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUANGDONG JUZHICHENG TECHNOLOGY Co Ltd filed Critical GUANGDONG JUZHICHENG TECHNOLOGY Co Ltd
Priority to CN201410772037.6A priority Critical patent/CN104491795A/en
Publication of CN104491795A publication Critical patent/CN104491795A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238Saposhnikovia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/646Arachnids, e.g. spiders, scorpions, ticks or mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • A61K36/12Filicopsida or Pteridopsida
    • A61K36/126Drynaria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/29Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296Epimedium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/487Psoralea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts, ocular implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the technical field of medicines and discloses a traditional Chinese medicine composition for treating rheumatoid arthritis. The traditional Chinese medicine composition is mainly prepared from the following raw materials in parts by weight: 11-33 parts of ledebouriella seseloides, 11-33 parts of angelica sinensis, 5-15 parts of rhizoma drynariae, 3-12 parts of fructus psoraleae, 3-12 parts of epimedium, 3-12 parts of dried whole scorpion, 3-12 parts of dipsacus root, 3-12 parts of dried ginger, 1-6 parts of radix astragali and 11-33 parts of glycyrrhiza uralensis. The traditional Chinese medicine composition disclosed by the invention can interact, has the effects of nourishing the liver and kidneys, detoxifying and reducing swelling, dispelling wind and eliminating dampness, promoting blood circulation and dredging collaterals, strengthening the muscles and bones, expelling wind and clearing away cold and strengthening the body resistance to eliminate pathogenic factors during combined use, and can be used as a medicine for treating rheumatoid arthritis.

Description

A kind of Chinese medicine composition for the treatment of rheumatoid arthritis
Technical field
The invention belongs to medical art, relate to a kind of Chinese medicine composition for the treatment of rheumatoid arthritis and preparation method thereof.
Background technology
Rheumatoid arthritis (RA) is not bright chronic, the systemic disease based on inflammatory synovitis of a kind of cause of disease.It is characterized in that the multi-joint of hands, sufficient Minor articulus, symmetry, aggressive arthritis, often involved the serum rheumatoid factor (SRF) positive with organ outside joint, joint deformity and afunction can be caused.
Rheumatoid arthritis can with losing weight, the General Symptoms such as low grade fever and tired sense.1) morning is stiff: the inflexible subjective sensation of WA joint motion in morning, it is the non-specific performance of one of arthritis, and its persistent period is directly proportional to the order of severity of inflammation.2) performance of joint involvement 1. multi-joint to get involved symmetrically property polyarthritis (normal >=5 joints).There are hands, foot, wrist, ankle and temporomandibular joint etc. in the joint of easily getting involved, and other also can have elbow, shoulder, cervical vertebra, hip, knee joint etc.2. the deformity of joint deformity hands has fusiformis swelling, ulnar side deflection, swan neck deformity, buttonhole style deformity etc.What sufficient deformity had the downward subluxation of head of metatarsal bone to cause faces upward microdactyly, valgus deformity, metatarsophalangeal joints subluxation, bends in hammer toe and talipes valgus.3. other Wan Guan ∕ tarsal tunnel syndromes that median nerve/posterior tibial nerve pressurized can be had to cause, Articular effusion in knee joint clamp-ons Xing Cheng popliteal cyst (Baker cyst) on rear side of joint, cervical vertebra is got involved (the 2nd, 3 cervical vertebras common) can have cervical pain, neck weakness and be difficult to keep its normal position, atlanto-axial subluxation, should have the performance of compression of spinal cord and vertebro-basilar artery insufficiency mutually.3) 1. extra-articular manifestation generally shows can heating, rheumatoid nodules (belongs to the granuloma of machine, relevant with high titre RF, serious destruction of joint and RA activity, be apt to occur in the knuckle portions, joint such as ancon, joint olecranon are prominent, sacrum portion and frequent pressurized place), rheumatoid vasculitis (mainly involve arteriolar necrotizing arteriolitis, finger, toe end necrosis, skin ulcer, peripheral neuropathy etc. can be shown as) and lymphadenectasis.2. Cardiac Involvemant can have tuberosity, myocarditis, coronaritis, aortitis, the conductive impairment of pericarditis, pericardial effusion, visceral pericardium, cardiac muscle and valve, the performances such as chronic endocarditis and cardiac valve fibrosis.3. respiratory system is got involved can pleuritis, hydrothorax, pulmonary arteritis, interstitial lung disease, nodositas pneumonopathy etc.4. kidney performance mainly contains primary glomerular and tubulointerstitial nephritis, kidney amyloidosis and is secondary to the renal damage of Drug therapy (golden preparation, penicillamine and NSAIDs).5. nervous system is except the symptom of peripheral nerve pressurized, also can inducing neural disease, myelopathy, peripheral neurophaty, be secondary to vasculitic ischemia neuropathy, muscular hypertrophy and drug-induced nervous system lesion.6. anemia is the modal extra-articular manifestation of RA, belongs to study on anemia of chronic disease, is often mild to moderate.7. digestive system can because of caused by RA vasculitis, complication or Drug therapy.8. eye juvenile patient can have uveitis, and adult can have scleritis, may caused by vasculitis.Also can there be the perforation of drying property conjunctivokeratitis, scleromalacia, scleromalacia, corneal solution.4) the RA patient of Felty syndrome 1% can have splenomegaly, Neutrophilic granulocytopenia (and thrombocytopenia, red blood cell count(RBC) reduce), often has RF and ANA of serious arthropathy, high titre positive, belongs to a kind of Severe RA.5) palliative seronegativity, symmetry synovitis companion pitting edema syndrome (RS3PE) male are common, often in 55 years old with sequela, in acute onset, have the inflammation of symmetry carpal joint, flexor tendon sheath and hands Minor articulus, the back of the hand can have pitting edema.Stiff time in morning long (0.5 ~ 1 day), but RF is negative, and x-ray does not have osteoclasia more.There is the patient of 56% for the HLA-B7 positive.Poor to alone NSAIDs drug reaction in treatment, and low dose of glucocorticoid is evident in efficacy.Often spontaneous remission after 1 year, good prognosis.6) a kind of rare RA type that alternately occurs with alleviation with the acute attack of high heat, arthritis, erythra etc. of adult Still disease (AOSD).Gain the name because clinical manifestation is similar to whole body disease type juvenile rheumatoid arthritis (Still is sick).Some patients changes typical RA into through outbreak for several times.7) RA of Late-onset normal >65 year onset, sex difference is little, how in acute onset, development very fast (part be show at first with OA, occurs that typical RA shows after several years).With brothers' edema, canalis carpi and tarsal tunnel syndrome and polymyalgia for outstanding behaviours, morning is obviously stiff, and 60% ~ 70%RF is positive, but titre is much lower.X-ray is based on osteoporosis, and little aggressive changes.Complication such as patient Chang Yin cardiovascular, infection and impaired renal function and dead.Select NSAIDs to want prudent, low dose of hormone can be applied, to acting on antirheumatic (SAARD) reaction slowly better.
The main purpose for the treatment of rheumatoid arthritis is that ameliorate osteoarthritis disease is reacted, and suppresses pathological development and irreversible bone destruction, the as far as possible function of Saving cortilage and muscle, finally reaches the target of state of an illness complete incidence graph or low disease activity.Drug therapy mainly comprises nonsteroidal anti-inflammatory agent, acts on antirheumatic, immunosuppressant, immunity and biological preparation and plant amedica etc. slowly.1) nonsteroidal anti-inflammatory agent has antiinflammatory, pain relieving, refrigeration function, is medicine the most conventional in treating rheumatoid arthritis, is applicable to the patient in each periods such as active stage.Conventional medicine comprises diclofenac, nabumetone, meloxicam, celecoxib etc.2) antirheumatic (DMARDs) is otherwise known as Second line Drug or act on antirheumatic slowly.Conventional has methotrexate, oral or quiet note; Sulfasalazine, from low dose, increases progressively gradually, and oxychloroquine, leflunomide, ciclosporin, auranofin, Radix Paeoniae Alba total glucosides etc.3) glucocorticoid, 4) biological preparation, 5) plant amedica, the existing multiple plant amedica for rheumatoid arthritis, as Radix Tripterygii Wilfordii, white peony root's total glycoside, sinomenine etc.
Summary of the invention
The invention provides a kind of Chinese medicine composition for the treatment of rheumatoid arthritis.
The technical scheme that the present invention takes is as follows:
Treat a Chinese medicine composition for rheumatoid arthritis, be prepared from by the raw material of following weight portion:
Radix Saposhnikoviae 11-33, Radix Angelicae Sinensis 11-33, Rhizoma Drynariae 5-15, Fructus Psoraleae 3-12, Herba Epimedii 3-12, Scorpio 3-12, Radix Dipsaci 3-12, Rhizoma Zingiberis 3-12, Radix Astragali 1-6, Radix Glycyrrhizae 11-33.
As optimal technical scheme, the present invention treats the Chinese medicine composition of rheumatoid arthritis, is prepared from by the raw material of following weight portion:
Radix Saposhnikoviae 24, Radix Angelicae Sinensis 24, Rhizoma Drynariae 10, Fructus Psoraleae 6, Herba Epimedii 6, Scorpio 4, Radix Dipsaci 4, Rhizoma Zingiberis 6, the Radix Astragali 3, Radix Glycyrrhizae 18.
Two of the object of the invention there is provided a kind of preparation method for the treatment of the Chinese medicine composition of rheumatoid arthritis, and concrete steps are as follows:
1) take each traditional Chinese medicinal material raw materials by proportioning, then put into Chinese medicine grinder respectively and pulverize, grinding and sieving;
2) fine drug powder of the Radix Saposhnikoviae of step 1) being prepared, Radix Angelicae Sinensis, Rhizoma Drynariae, Fructus Psoraleae, Rhizoma Zingiberis, the Radix Astragali, Radix Glycyrrhizae adds in container, adds the dehydrated alcohol of 6-10 times amount, reflux, extract, 1-3 hour, collects extracting solution after cooling;
3) toward step 2) add the water of 3-6 times amount in gained medicinal residues, reflux, extract, 1-4 hour, collects extracting solution after cooling;
4) merge the extracting solution of twice, leave standstill and obtain supernatant; It is the thick paste of 1.10-1.20 that supernatant heating is concentrated into relative density at 60 DEG C;
5) in thick paste, add the fine drug powder of Herba Epimedii, Scorpio, Radix Dipsaci, drying obtains dry extract;
6) carried out by dry extract pulverizing, sieving, add adjuvant, mixing, makes required dosage form according to a conventional method.
The present invention treat the middle compositions determined curative effect of rheumatoid arthritis and also therapeutic effect good, can expelling wind and removing dampness, removing toxic substances and promoting subsidence of swelling, promoting blood circulation to remove obstruction in the collateral, nourishing the liver and kidney, strengthening the tendons and bones and strengthening vital QI to eliminate pathogenic factors.Prove through clinical trial, traditional Chinese medicine composition for treating rheumatoid arthritis cure rate of the present invention is high, due to existing medicine, can promote the use of.
Detailed description of the invention
Further describe the present invention below by way of detailed description of the invention, but the present invention is not limited only to following examples.Within the scope of the invention or not departing from content of the present invention, spirit and scope, Chinese medicine composition of the present invention is suitably improved, replaces the identical component of effect, will become apparent to those skilled in the art that they are all deemed to be included within scope of the present invention.
Embodiment 1
Formula (kg):
Radix Saposhnikoviae 22, Radix Angelicae Sinensis 30, Rhizoma Drynariae 6, Fructus Psoraleae 6, Herba Epimedii 4, Scorpio 5, Radix Dipsaci 5, Rhizoma Zingiberis 12, Huang 6, Radix Glycyrrhizae 20.
Preparation method:
1) take each traditional Chinese medicinal material raw materials by proportioning, then put into Chinese medicine grinder respectively and pulverize, after pulverizing, obtain coarse powder;
2) fine drug powder of the Radix Saposhnikoviae of step 1) being prepared, Radix Angelicae Sinensis, Rhizoma Drynariae, Fructus Psoraleae, Rhizoma Zingiberis, the Radix Astragali, Radix Glycyrrhizae adds in container, adds the dehydrated alcohol of 10 times amount, and reflux, extract, 2 hours, collects extracting solution after cooling;
3) toward step 2) add the water of 3 times amount in gained medicinal residues, reflux, extract, 2 hours, collects extracting solution after cooling;
4) merge the extracting solution of twice, leave standstill and obtain supernatant; It is the thick paste of 1.10-1.20 that supernatant heating is concentrated into relative density at 60 DEG C;
5) in thick paste, add the fine drug powder of Herba Epimedii, Scorpio, Radix Dipsaci, drying obtains dry extract;
6) carried out by dry extract pulverizing, crossing 150 mesh sieves, add adjuvant, mixing, makes granule according to a conventional method.
Embodiment 2
Formula (kg):
Radix Saposhnikoviae 24, Radix Angelicae Sinensis 24, Rhizoma Drynariae 10, Fructus Psoraleae 6, Herba Epimedii 6, Scorpio 4, Radix Dipsaci 4, Rhizoma Zingiberis 6, the Radix Astragali 3, Radix Glycyrrhizae 18
Preparation method:
1) take each traditional Chinese medicinal material raw materials by proportioning, then put into Chinese medicine grinder respectively and pulverize, after pulverizing, obtain coarse powder;
2) fine drug powder of the Radix Saposhnikoviae of step 1) being prepared, Radix Angelicae Sinensis, Rhizoma Drynariae, Fructus Psoraleae, Rhizoma Zingiberis, the Radix Astragali, Radix Glycyrrhizae adds in container, adds the dehydrated alcohol of 10 times amount, and reflux, extract, 3 hours, collects extracting solution after cooling;
3) toward step 2) add the water of 6 times amount in gained medicinal residues, reflux, extract, 2 hours, collects extracting solution after cooling;
4) merge the extracting solution of twice, leave standstill and obtain supernatant; It is the thick paste of 1.10-1.20 that supernatant heating is concentrated into relative density at 60 DEG C;
5) in thick paste, add the fine drug powder of Herba Epimedii, Scorpio, Radix Dipsaci, drying obtains dry extract;
6) carried out by dry extract pulverizing, crossing 150 mesh sieves, add adjuvant, mixing, makes capsule according to a conventional method, and every containing crude drug 0.5g.
Embodiment 3
Formula (kg):
Radix Saposhnikoviae 11, Radix Angelicae Sinensis 12, Rhizoma Drynariae 12, Fructus Psoraleae 12, Herba Epimedii 12, Scorpio 12, Radix Dipsaci 12, Rhizoma Zingiberis 12, the Radix Astragali 6, Radix Glycyrrhizae 33.
Preparation method:
1) take each traditional Chinese medicinal material raw materials by proportioning, then put into Chinese medicine grinder respectively and pulverize, after pulverizing, obtain coarse powder;
2) fine drug powder of the Radix Saposhnikoviae of step 1) being prepared, Radix Angelicae Sinensis, Rhizoma Drynariae, Fructus Psoraleae, Rhizoma Zingiberis, the Radix Astragali, Radix Glycyrrhizae adds in container, adds the dehydrated alcohol of 8 times amount, and reflux, extract, 2 hours, collects extracting solution after cooling;
3) toward step 2) add the water of 4 times amount in gained medicinal residues, reflux, extract, 2 hours, collects extracting solution after cooling;
4) merge the extracting solution of twice, leave standstill and obtain supernatant; It is the thick paste of 1.10-1.20 that supernatant heating is concentrated into relative density at 60 DEG C;
5) in thick paste, add the fine drug powder of Herba Epimedii, Scorpio, Radix Dipsaci, drying obtains dry extract;
6) carried out by dry extract pulverizing, crossing 150 mesh sieves, add adjuvant, mixing, makes tablet according to a conventional method, and every sheet is containing crude drug 0.5g.
Embodiment 4
Formula (kg):
Radix Saposhnikoviae 33, Radix Angelicae Sinensis 22, Rhizoma Drynariae 11, Fructus Psoraleae 11, Herba Epimedii 11, Scorpio 7, Radix Dipsaci 8, Rhizoma Zingiberis 4, the Radix Astragali 4, Radix Glycyrrhizae 33.
Preparation method:
1) take each traditional Chinese medicinal material raw materials by proportioning, then put into Chinese medicine grinder respectively and pulverize, after pulverizing, obtain coarse powder;
2) fine drug powder of the Radix Saposhnikoviae of step 1) being prepared, Radix Angelicae Sinensis, Rhizoma Drynariae, Fructus Psoraleae, Rhizoma Zingiberis, the Radix Astragali, Radix Glycyrrhizae adds in container, adds the dehydrated alcohol of 8 times amount, and reflux, extract, 2 hours, collects extracting solution after cooling;
3) toward step 2) add the water of 4 times amount in gained medicinal residues, reflux, extract, 2 hours, collects extracting solution after cooling;
4) merge the extracting solution of twice, leave standstill and obtain supernatant; It is the thick paste of 1.10-1.20 that supernatant heating is concentrated into relative density at 60 DEG C;
5) in thick paste, add the fine drug powder of Herba Epimedii, Scorpio, Radix Dipsaci, drying obtains dry extract;
6) carried out by dry extract pulverizing, crossing 150 mesh sieves, add adjuvant, mixing, makes oral liquid according to a conventional method.
clinical data:
1, MethodsThe cases enrolled diagnostic criteria
Adopt ARA diagnostic criteria in 1987.Rheumatoid arthritis feelings activity standard:
(1) moderate during rest pain;
(2) morning, the stiff time was more than or equal to 1 hour;
More than (3) three arthroncuss;
(4) articular pain is more than or equal to 5 joints;
(5) ESR is greater than 28mm/hr.
Meet above 4 namely diagnosable.
2, physical data
Experiment observes 200 routine patient with rheumatoid arthritis altogether, and all patients are divided into two groups at random, treatment group 120 example, and matched group 80 example, two groups of patient ages, sex, symptoms verify that through statistics zero difference has comparability.
3, Therapeutic Method
Treatment group: take capsule prepared by the embodiment of the present invention 2, each 6,3 times on the one;
Matched group: give conventional western medicine treatment (taking leflunomide, methotrexate and folic acid).
Continuous treatment 30 days.
4, evaluation of clinical curative effect standard
To joint swelling index, articular pain index, morning is stiff, grip, and ESR, RF examine, and the improvement degree of every index is calculated as follows:
Value × 100% before (before treatment the rear value of value-treatment)/treatment;
ESR calculates:
(before treatment the rear value of value-treatment)/(before treatment value-normal value) × 100%;
(male normal value is less than or equal to 15mm/hr, and female is less than or equal to 20mm/hr)
Curative effect classification:
Calculate the improvement percent of indices, addition calculates it and on average improves percent to judge curative effect.
Effective: than before treatment after treatment, improvement rate >=70%.
Effective: than before treatment after treatment, 50%≤improvement rate < 70%.
Improve: than before treatment after treatment, 30%≤improvement rate < 50%.
Invalid: than before treatment after treatment, improvement rate < 30%.
5, therapeutic outcome
Two groups of therapeutic outcomes, ginseng is shown in Table 1.
Table 1, two groups for the treatment of curative effects
Group Number of cases Effective Effectively Improve Invalid Total effective rate (%)
Treatment group 120 48 34 26 12 90.0%
Matched group 80 24 18 15 23 71.3%
From the above results, the present invention treats the evident in efficacy of rheumatoid arthritis Chinese medicine composition and is better than western medicine group.

Claims (3)

1. treat a Chinese medicine composition for rheumatoid arthritis, it is characterized in that, its raw material primarily of following weight portion is prepared from:
Radix Saposhnikoviae 11-33, Radix Angelicae Sinensis 11-33, Rhizoma Drynariae 5-15, Fructus Psoraleae 3-12, Herba Epimedii 3-12, Scorpio 3-12, Radix Dipsaci 3-12, Rhizoma Zingiberis 3-12, Radix Astragali 1-6, Radix Glycyrrhizae 11-33.
2. the Chinese medicine composition for the treatment of rheumatoid arthritis as claimed in claim 1, it is characterized in that, the raw material primarily of following weight portion is prepared from:
Radix Saposhnikoviae 24, Radix Angelicae Sinensis 24, Rhizoma Drynariae 10, Fructus Psoraleae 6, Herba Epimedii 6, Scorpio 4, Radix Dipsaci 4, Rhizoma Zingiberis 6, the Radix Astragali 3, Radix Glycyrrhizae 18.
3. the Chinese medicine composition for the treatment of rheumatoid arthritis as claimed in claim 1 or 2, it is characterized in that, its preparation method, concrete steps are as follows:
1) take each traditional Chinese medicinal material raw materials by proportioning, then put into Chinese medicine grinder respectively and pulverize, grinding and sieving;
2) fine drug powder of the Radix Saposhnikoviae of step 1) being prepared, Radix Angelicae Sinensis, Rhizoma Drynariae, Fructus Psoraleae, Rhizoma Zingiberis, the Radix Astragali, Radix Glycyrrhizae adds in container, adds the dehydrated alcohol of 6-10 times amount, reflux, extract, 1-3 hour, collects extracting solution after cooling;
3) toward step 2) add the water of 3-6 times amount in gained medicinal residues, reflux, extract, 1-4 hour, collects extracting solution after cooling;
4) merge the extracting solution of twice, leave standstill and obtain supernatant; It is the thick paste of 1.10-1.20 that supernatant heating is concentrated into relative density at 60 DEG C;
5) in thick paste, add the fine drug powder of Herba Epimedii, Scorpio, Radix Dipsaci, drying obtains dry extract;
6) carried out by dry extract pulverizing, sieving, add adjuvant, mixing, makes required dosage form according to a conventional method.
CN201410772037.6A 2014-12-16 2014-12-16 Traditional Chinese medicine composition for treating rheumatoid arthritis Pending CN104491795A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410772037.6A CN104491795A (en) 2014-12-16 2014-12-16 Traditional Chinese medicine composition for treating rheumatoid arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410772037.6A CN104491795A (en) 2014-12-16 2014-12-16 Traditional Chinese medicine composition for treating rheumatoid arthritis

Publications (1)

Publication Number Publication Date
CN104491795A true CN104491795A (en) 2015-04-08

Family

ID=52933309

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410772037.6A Pending CN104491795A (en) 2014-12-16 2014-12-16 Traditional Chinese medicine composition for treating rheumatoid arthritis

Country Status (1)

Country Link
CN (1) CN104491795A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101380453A (en) * 2008-07-21 2009-03-11 刘翠侠 Oral powder and external plaster for treating hyperosteogeny and atrophic arthritis and production method thereof
CN101474396A (en) * 2009-02-06 2009-07-08 王晓敏 Pharmaceutical composition for treating rheumatism and atrophic arthritis
CN102038758A (en) * 2011-01-05 2011-05-04 殷广全 Rheumatism preparation used for treating rheumatism
CN102294009A (en) * 2011-08-31 2011-12-28 宋立学 Chinese medicinal composition for treating rheumatoid arthritis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101380453A (en) * 2008-07-21 2009-03-11 刘翠侠 Oral powder and external plaster for treating hyperosteogeny and atrophic arthritis and production method thereof
CN101474396A (en) * 2009-02-06 2009-07-08 王晓敏 Pharmaceutical composition for treating rheumatism and atrophic arthritis
CN102038758A (en) * 2011-01-05 2011-05-04 殷广全 Rheumatism preparation used for treating rheumatism
CN102294009A (en) * 2011-08-31 2011-12-28 宋立学 Chinese medicinal composition for treating rheumatoid arthritis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
中华中医药学会: "类风湿性关节炎诊疗指南", 《中国中医药现代远程教育》 *
张颖等: "中医治疗类风湿性关节炎体会", 《中国医药指南》 *
郭福等: "中西医结合治疗类风湿性关节炎72例疗效观察", 《中医临床研究》 *

Similar Documents

Publication Publication Date Title
CN101297946B (en) Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof
CN102284028B (en) Medicine for treating rheumatoid arthritis
CN100394955C (en) Chinese traditional medicine preparation for treating bone fracture and traumatic injury
CN103735791B (en) A kind of Chinese medicine composition and preparation method thereof for the treatment of lumbar vertebra, bone diseases
CN105560662A (en) External-use traditional Chinese medicine composition for treating knee osteoarthritis
CN104689173B (en) A kind of compound Chinese medicinal preparation for treating gout
CN103735927B (en) A kind of Chinese medicine composition for the treatment of acute stage of gout and preparation method thereof
CN104721426A (en) Traditional Chinese medicine composition for promoting fracture healing
CN104667035A (en) Medicament for treating gout
CN103550380A (en) Traditional Chinese medicine composition for treating hyperostosis
WO2021042275A1 (en) Traditional chinese medicine composition for treating osteoarthritis
CN102526275B (en) Pharmaceutical for curing gout and preparation method thereof
CN104069392A (en) Hmong medicine for treating gout
CN101703619A (en) Chinese medicament for treating hyperosteogeny and osteoarthritis
CN103623350A (en) Traditional Chinese medicine plaster with effect of boosting fracture healing
CN104491795A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis
CN104491009A (en) Use of traditional Chinese medicine composition in preparation of drug for treating rheumatoid arthritis
CN105169279A (en) Traditional Chinese medicine composition for treating knee joint bone hyperplasia
CN104225112A (en) Traditional Chinese medicinal composition for curing osteoarthritis
CN101953908A (en) Chinese medicinal composition for treating pain in waist and lower extremities and preparation method thereof
CN102805803B (en) Traditional Chinese medicine for treating rheumatoid arthritis
CN101496849B (en) Chinese medicine preparation for treating atrophic arthritis
CN102343010B (en) Chinese medicinal composition for treating prolapse of lumbar intervertebral disc
CN104547086A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis
CN105412889A (en) Traditional Chinese medicinal honeyed pill for treating lumbar intervertebral disc protrusion, and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150408

RJ01 Rejection of invention patent application after publication